Literature DB >> 17364207

[Modern diagnosis and treatment of urticaria: five case reports].

D Wieczorek1, U Raap, A Kapp, B Wedi.   

Abstract

The different urticaria subtypes represent a common diagnostic and treatment challenge for the dermatologist. Usually, acute urticaria is treated symptomatically with modern H1 antihistamines and, if needed, short courses of glucocorticosteroids. In acute urticaria which is often induced by an acute infection no further diagnostic procedures are recommended. In contrast, a targeted work-up followed by specific therapy is required for chronic urticaria, physical urticaria and special urticaria types, because many of these subtypes are characterized by their persistence for several years and have a profound impact on the quality of life. This article elucidates the management of urticaria by presenting five characteristic case reports of patients managed in a special urticaria consulting hour.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364207     DOI: 10.1007/s00105-007-1287-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  11 in total

Review 1.  [Current position of the role of allergic and non-allergic food hypersensitivity in urticaria].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

Review 2.  [Evidence-based treatment of urticaria].

Authors:  B Wedi; A Kapp
Journal:  Dtsch Med Wochenschr       Date:  2006-07-14       Impact factor: 0.628

Review 3.  Evidence-based therapy of chronic urticaria.

Authors:  Bettina Wedi; Alexander Kapp
Journal:  J Dtsch Dermatol Ges       Date:  2007-02       Impact factor: 5.584

Review 4.  EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria.

Authors:  T Zuberbier; C Bindslev-Jensen; W Canonica; C E H Grattan; M W Greaves; B M Henz; A Kapp; M M A Kozel; M Maurer; H F Merk; T Schäfer; D Simon; G A Vena; B Wedi
Journal:  Allergy       Date:  2006-03       Impact factor: 13.146

Review 5.  EAACI/GA2LEN/EDF guideline: management of urticaria.

Authors:  T Zuberbier; C Bindslev-Jensen; W Canonica; C E H Grattan; M W Greaves; B M Henz; A Kapp; M M A Kozel; M Maurer; H F Merk; T Schäfer; D Simon; G A Vena; B Wedi
Journal:  Allergy       Date:  2006-03       Impact factor: 13.146

6.  Chronic urticaria: assessment of current treatment.

Authors:  Bettina Wedi; Alexander Kapp
Journal:  Expert Rev Clin Immunol       Date:  2005-09       Impact factor: 4.473

7.  Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs.

Authors:  B Wedi; V Novacovic; M Koerner; A Kapp
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

Review 8.  Helicobacter pylori infection in skin diseases: a critical appraisal.

Authors:  Bettina Wedi; Alexander Kapp
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

9.  [Chronic urticaria in childhood].

Authors:  D Wieczorek; U Raap; T Liekenbröcker; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

Review 10.  [New therapeutic strategies for the different subtypes of urticaria].

Authors:  U Raap; T Liekenbröcker; D Wieczorek; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

View more
  2 in total

1.  [Urticaria. Sometimes IgE-mediated?].

Authors:  D Wieczorek; J Langhorst; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

2.  [Sociomedical implications of the inability to commute in patients with cold urticaria].

Authors:  W Nürnberg; J Grabbe; H-J Glawe; R Stoll
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.